Single-Fascicle Neural Decoding
Captures and decodes peripheral neuromuscular signals at single-fascicle resolution. Proprietary filtering algorithms separate true motor intent from physiological noise in real time.
The Fasikl-X™ Nerve-Computer Interface (NCI) represents a profound leap forward in bioelectronic medicine and neural engineering. Built upon over two decades of foundational research in microelectronics, neuro-interface engineering, and biosignal processing, Fasikl-X establishes a high-fidelity, bidirectional communication channel between peripheral nerves and cloud artificial intelligence.
Drawing inspiration from the philosophical concept of the "unity of knowledge and action," our scientific framework defines knowledge as real-time somatic awareness and action as precise physiological execution. Rather than bypassing or replacing human cognition, Fasikl-X creates a closed-loop system where the nervous system and AI algorithms continuously co-act, analyze physiological feedback, and co-evolve to deliver optimal therapeutic results.
Designed for clinical institutions, medical device integrators, and global research partners seeking high-precision neural modulation platforms.
Captures and decodes peripheral neuromuscular signals at single-fascicle resolution. Proprietary filtering algorithms separate true motor intent from physiological noise in real time.
Streams high-bandwidth neural data to cloud models. Algorithmic intelligence continuously re-calibrates closed-loop therapeutic impulses and sends micro-targeted modulation back to the body.
Engineered under rigorous ISO 13485 quality management systems and FDA design controls, prioritizing noninvasive biosensing safety while maintaining clinical efficacy.
Unlocking transformative applications for limb loss, motor paralysis, and refractory chronic pain management.
MindForce™ translates complex neural impulses into natural, multi-degree-of-freedom robotic limb movement for amputees, allowing users to execute intricate grip patterns directly through cognitive intent.
Provides an active neural interface channel for patients living with paralysis or neurodegenerative conditions, commanding assistive devices, robotic exoskeletons, and digital workstations.
Delivers recalibrated neuro-stimulation directly to targeted peripheral nerve structures, disrupting phantom limb pain and chronic neuropathic pain syndromes at their neural source.
Fasikl has earned two FDA Breakthrough Device Designations for the MindForce™ system, recognizing its potential to solve previously untreatable challenges in prosthetic control and pain management.
Fasikl actively collaborates with leading movement disorder centers, university research hospitals, bioelectronic device distributors, and commercial healthcare partners worldwide.